Linagliptin potentiates the effect of l-dopa on the behavioural, biochemical and immunohistochemical changes in experimentally-induced Parkinsonism: Role of toll-like receptor 4, TGF-β1, NF-κB and glucagon-like peptide 1. [electronic resource]
Producer: 20190131Description: 108-118 p. digitalISSN:- 1873-507X
- 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine -- administration & dosage
- Animals
- Antiparkinson Agents -- therapeutic use
- Carbidopa -- therapeutic use
- Disease Models, Animal
- Dose-Response Relationship, Drug
- Drug Combinations
- Drug Synergism
- Glucagon-Like Peptide 1 -- metabolism
- Levodopa -- therapeutic use
- Linagliptin -- therapeutic use
- Mice
- Mice, Inbred BALB C
- NF-kappa B -- metabolism
- Parkinsonian Disorders -- drug therapy
- Toll-Like Receptor 4 -- metabolism
- Transforming Growth Factor beta1 -- metabolism
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.